Category: Biomarkers
Biomarkers market research reports by Renub Research
-
Liquid Biopsy Market Report by Product (Kits & Reagents, Platforms & Instruments, and Services), Application (Cancer Therapeutic Application, Reproductive Health, and Other Therapeutic), Circulating Biomarkers (Circulating Tumour Cell, Circulating Tumour DNA, and Cell-free DNA), End-User (Hospitals, Diagnostic Laboratories, Point-of-care Testing, Academic Institutes, and Others) Countries and Company Analysis 2025-2033
Liquid Biopsy Market Report by Product (Kits & Reagents, Platforms & Instruments, and Services), Application (Cancer Therapeutic Application, Reproductive Health, and Other Therapeutic), Circulating Biomarkers (Circulating Tumour Cell, Circulating Tumour DNA, and Cell-free DNA), End-User (Hospitals, ... Read More
-
United States Liquid Biopsy Market Report by Cancer types (Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Liver Cancer, and Other Cancer), Products (Kits & Reagents, Platforms & Instruments, and Services), Application (Early Diagnosis, Patient Monitoring, and Recurrence Monitoring), Biomarkers (Circulating Tumor Cells (CTCs), Circulating Tumor DNA (ctDNA), Extracellular Vesicles (EVs), and Other Biomarker Types), Sample types (Blood, Urine, and Others), End-Users (Hospitals & Laboratories and Governments & Academic Research Centers), and Company Analysis 2024-2032
United States Liquid Biopsy Market Report by Cancer types (Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Liver Cancer, and Other Cancer), Products (Kits & Reagents, Platforms & Instruments, and Services), Application (Early Diagnosis, Patient Monitoring, and Recurrence Monitoring), ... Read More
-
Cancer Diagnostics Market, Size, Global Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Companies Analysis
Cancer Diagnostics Market, Size, Global Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Companies Analysis Cancer Diagnostics Market is projected to hit US$ 280.37 Billion by 2030, as per a report by Renub Research. Enabling early detection and precise identity of c ... Read More